![]() |
|
|
Molecular Pharmacology, Vol 5, 213-218, Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics
1 Departments of Pharmacology and Medicine, Yale University School of Medicine,
New Haven, Connecticut 06510
An antiserum has been prepared against dihydrofolate reductase (EC 1.5.1.3) from mouse L1210 R tumor cells by injection of the purified enzyme into rabbits. The antiserum both precipitates and inactivates the enzyme; the antigen-antibody interaction fixes complement. The antibody inactivates dihydrofolate reductase from L5178Y, Ehrlich ascites carcinoma, and Sarcoma 180 murine tumors as well as that from the L1210 lymphoma. It partially inactivates enzyme from human bone marrow, but does not inactivate enzyme from Escherichia coli or from mouse, chicken, guinea pig, or rabbit liver. The cofactor NADPH, the substrates dihydrofolate and folate, and the inhibitor methotrexate protect the enzyme from inactivation by the antibody at low concentration.
Submitted on November 9, 1968
This article has been cited by other articles:
![]() |
R. Schimke, R. Kaufman, F. Alt, and R. Kellems Gene amplification and drug resistance in cultured murine cells Science, December 8, 1978; 202(4372): 1051 - 1055. [Abstract] [PDF] |
||||